title: Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.
abstract: Familial combined hyperlipidemia (FCH) is a heritable lipid disorder, in which dense low-density lipoprotein (LDL) subfraction profiles due to a predominance of small dense LDL particles are frequently observed. These small dense LDL particles are associated with cardiovascular disease. Using segregation analysis, we investigated to what extent these LDL subfraction profiles are genetically determined; also, the mode of inheritance was studied. Individual LDL subfraction profiles were determined by density gradient ultracentrifugation in 623 individuals of 40 well-defined Dutch FCH families. The individual LDL subfraction profile was defined as a quantitative trait by the continuous variable K, a reliable estimate of the relative contribution of each LDL subfraction to the overall profile. Variation in parameter K due to age, sex, and hormonal status was taken into account by introducing liability classes. Segregation analysis was performed by fitting a series of class D regressive models, implemented in the Statistical Analysis for Genetic Epidemiology (SAGE) program, after which genetic models were compared using log-likelihood ratio tests. Our data show that 60% of the variability of parameter K could be explained by lipid and lipoprotein levels and that a major autosomal locus, recessively inherited, with a population frequency of .42 +/- .07, and an additional polygenic component of .25 best explained the clustering of atherogenic dense LDL subfraction profiles in these FCH families. Therefore, dense LDL subfraction profiles, associated with elevated lipid levels, appear to have a genetic basis in FCH.
authors.affiliation: Department of Medicine, University of Nijmegen, The Netherlands.
authors.forename: S J
authors.initials: SJ
authors.lastname: Bredie
authors.forename: L A
authors.initials: LA
authors.lastname: Kiemeney
authors.forename: A F
authors.initials: AF
authors.lastname: de Haan
authors.forename: P N
authors.initials: PN
authors.lastname: Demacker
authors.forename: A F
authors.initials: AF
authors.lastname: Stalenhoef
mesh_terms: D000293:Adolescent; D000367:Age Factors; D015992:Body Mass Index; D003276:Contraceptives, Oral; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000097:blood* / Q000235:genetics*; D016014:Linear Models; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D017698:Postmenopause; D017697:Premenopause; D012737:Sex Factors; D012907:Smoking / Q000009:adverse effects
chemical_list: D003276:Contraceptives, Oral; D008055:Lipids; D008077:Lipoproteins, LDL